Abstract
Background: Syncope is a symptom complex comprising of a brief loss of consciousness leading to a transient decrease in cerebral blood flow that resolves completely. 2D-transthoracic echocardiography (TTE) is a useful tool to detect underlying structural heart disease, which can lead to syncope, e.g., aortic stenosis, atrial masses. This study aimed to find the subgroups of patients with syncope who would benefit the most from a TEE. Methods: We did a retrospective chart review of all patients aged 18 years or older, admitted to our hospital with a primary diagnosis of syncope between January 2015 and January 2017 to determine the frequency and findings of echo in all these patients. The baseline characteristics, demographics were taken into account for the inclusion of these patients into the study. Results: A total of 369 patients were initially studied, but only 139 patients were included in the final analysis based on inclusion criteria. Among the high-risk patients (i.e., abnormal Physical exam and/or abnormal EKG, population), 43.75% had significant echocardiographic finding. While among low-risk patients (i.e., normal EKG and exam), 10% (9/91) had a significant finding. Patients with abnormal EKG or examination findings were 7.08 times (95% CI = 2.89-17.3) more likely to have an abnormal echocardiogram (P < 0.001). Conclusion: Our study suggests that the diagnostic yield of 2D-TTE in the absence of abnormal physical exam and/or abnormal EKG is very limited and may add an extra burden on the finances and resources of both the patient and the hospital.
Keywords: Syncope, electrocardiogram, transthoracic echocardiography, diagnosis
Introduction
A syncope is an event of transient loss of consciousness. It is a symptom explained by a brief loss of consciousness with an inability to maintain postural tone because of a transitory decrease in cerebral blood flow [1]. Syncope is usually self-resolving event without requiring further management. The differential diagnosis of syncope includes seizure, hypoglycemia, coma, shock, and other states of change in mental status or altered consciousness. It is a prevalent clinical condition with a vast number of different causes. It is one of the most common reasons of emergency room visits and hospital admissions and may lead to extensive workup [2]. It is estimated that it is the cause of 3% of all ED and 1-6% of all hospital visits and around 40% of those cases need to be admitted [3,4]. Beyond this, there is also a recurrence rate of almost 35% [4]. The prevalence of syncope is about 42%, considering a lifetime of 70 years and has an annual incidence of 6% [5]. As per the prior studies, its frequency varies from 15% (below 18 years of age) to 39% among medical students, reaching 23% among the elderly [6-8]. In the general population, the frequency of syncope is about 18.1-39.7 per 1000 patients, with a similar incidence between genders, and high prevalence between 10 and 30 years of age, mainly because of vasovagal syncope [5]. The first reported incidence of syncope was 6.2 per 1000 person-years. However, there is a significant increase in the incidence of syncope after 70 years of age, with 5.7 episodes/1000 individuals per year between 60 and 69 years old and with 11.1 episodes/1000 individuals per year between 70- and 79-years’ age. After 80 years, the annual incidence may reach 19.5 per 1000 individuals [9].
We performed a retrospective analysis to look into the characteristics of patients presenting with syncope and investigated diagnostic yield of echocardiography in syncope cases. The purpose of this study was: 1) to examine the frequency with which echocardiography was used in the evaluation of patients admitted to our hospital because of syncope who have a normal clinical examination and normal electrocardiogram and 2) to determine any additional benefit in diagnosis contributed by the echocardiogram, over and above that provided by the initial history, physical examination, and electrocardiography.
Material and methods
This study is a retrospective observational analysis performed at Abington Jefferson Hospital, a teaching hospital in Abington, PA. Data collected over the 12 months from January 1, 2015, to January 31, 2017. Data collection was focused on determining the rate of performing echo, and the frequency of findings in patients over 18 years of age with syncope. Syncope cases were identified based on presenting illness at the time of presentation. The data collected from medical records include history/physical examination, demographic variables, EKG, and echocardiographic findings. An EKG and Echocardiogram were performed by trained technicians and read by a senior cardiologist. Analysis was performed using the SPSS. Categorical data was analysed using the Pearson chi square with an alpha criteria of p value of 0.05 as a significant value.
We set strict inclusion criteria, and eventually included only 139 of the 369 patients. The baseline characteristics, demographics were taken into account for these patients. All the 139 patients included met the following selection criteria.
Inclusion criteria
(1) All patients admitted to an observation unit and are over the age of 18 years admitted with the primary diagnosis of syncope that had an abnormal EKG and echocardiogram during the index admission. (2) Abnormal EKG findings include abnormal axis, ischemic changes, conduction blocks including first degree, second degree, third-degree blocks, bi-fascicular blocks, abnormal QTc (short or prolonged QTc), and left bundle branch block. (3) Abnormal echocardiogram findings include ejection fraction less than 45%, valvular abnormalities, ventricular hypertrophy, outflow tract obstruction, pericardial effusion, and pulmonary hypertension. (4) Patients with standard cardiac biomarkers including troponin-I or t and CK-MB if checked as part of their evaluation.
Exclusion criteria
(1) Those patients with a misdiagnosis of syncope (e.g., seizure, myocardial infarction). (2) Patients who were transferred to another acute care hospital. (3) Patients who left against medical advice on index admission. (4) Patients with syncope diagnosis who did not get an echocardiogram. (5) Patients who had positive cardiac biomarkers, including troponin-I or t and CK-MB.
Results
Out of 139 patients admitted to an observation unit with a primary diagnosis of syncope, 80% of the patients were over 65 years of age. Amongst the included patients, 42% were male, and 58% were females. The included population also had at least one comorbid condition accounting for syncope. These comorbidd conditions with percentage of prevalence in this population provides hypertension (63%), followed by diabetes mellitus (16%), CKD (11%), prior myocardial infarction and previous syncope (10%), CVA (8.6%), anemia (5%) and peripheral vascular disease present in only (4%) of patients. The demographic variables and prevalence of comorbid conditions are shown in Tables 1 and 2.
Table 1.
Demographics of patients | Percentage (%) |
---|---|
Total patient population (n) | 139 (100%) |
Age > 65 years | 80% |
Age < 65 years | 20% |
Males | 42% |
Females | 58% |
Table 2.
Risk factors | Percentage of the population |
---|---|
Hypertension | 63% |
Diabetes Mellitus | 16% |
Prior Myocardial infarction | 10% |
Prior percutaneous intervention | 7.9% |
Chronic Kidney Disease | 11.5% |
Prior cerebrovascular accident | 8.6% |
Peripheral vascular disease | 4.3% |
Anemia | 5.0% |
Prior syncope | 10% |
The normal and abnormal physical exam, EKG and echo findings in our patient population are depicted in Table 3.
Table 3.
Parameters | Percentage of the population (total n = 139) | |
---|---|---|
| ||
Normal/Present | Abnormal/Absent | |
EKG | 78.5% | 21.5% |
Physical Exam | 87% | 13% |
Left ventricular systolic dysfunction (LVEF < 50%) | 95% | 5% |
Valvular Heart disease | 12.7% | 87.3% |
Abnormal Orthostatic Blood Pressure | 12.3% | 87.7% |
The majority of patients (87%) had a normal physical examination, and 13% had an abnormal physical examination. Patients with abnormal examination had abnormal findings on TTE in only 36% (7/19) cases while less than 1% patients of the normal physical examination group had positive findings on echocardiography. The prevalence of positive TTE findings in the abnormal physical exam group was significantly higher than the normal physical exam group, and the difference was statistically significant (P = 0.001). These results are shown in Table 4.
Table 4.
Analyte | Echocardiography positive n = 8 | Echocardiography negative n = 131 | Total patients n = 139 |
---|---|---|---|
Normal physical exam (87%) | 1/120 (0.8%) | 119/120 (99.1%) | n = 120 (87%) |
Abnormal physical exam (13%) | 7/19 (36%) | 12/19 (64%) | n = 19 (13%) |
The majority of our patients had a normal EKG (78.5%). Approximately one-fifth (21.5%) of the patients had an abnormal EKG, but only 23% of those had positive echocardiographic findings. The difference in positive TTE findings in the normal and abnormal EKG groups was statistically significant (P < 0.05). This is depicted in Table 5.
Table 5.
Analyte | Echocardiography positive | Echocardiography negative | Total patients n = 139 |
---|---|---|---|
Normal EKG | 2/109 (2%) | 107/109 (98%) | n = 109 (78.5%) |
Abnormal EKG | 7/30 (23%) | 23/30 (77%) | n = 30 (21.5%) |
The relationship of abnormal echocardiography with following variables; abnormal physical examination, abnormal EKG, orthostatic vitals are given in Table 6.
Table 6.
Difference of positive echocardiography findings between population subgroups | Statistical significance |
---|---|
Murmur positive vs no murmur on physical examination | P = 0.000 |
Abnormal EKG vs normal EKG | P = 0.046 |
Orthostatic hypotension vs normal Orthostatic vitals | P = 1.000 |
Prior PCI vs no prior PCI | P = 0.059 |
The prevalence of positive TTE finding in patients with an abnormal physical exam or an abnormal EKG is described above. This becomes more significant when we consider patients with abnormal physical exam and EKG findings together. Among the high-risk patients (i.e., abnormal Physical exam and/or an abnormal EKG patient population), 43.75% (21/48) had a significant echocardiographic finding. While among low-risk patients (i.e., normal EKG and physical exam), 10% (9/91) had a significant finding. Patients with abnormal EKG or examination findings were 7.08 times (95% CI = 2.89-17.3) more likely to have an abnormal echocardiogram (P < 0.001).
Discussion
Most of the causes of syncope can be classified into four categories. These are reflex syncope, also called neural syncope, orthostatic syncope, cardiac arrhythmia, and cardiopulmonary disease leading to syncope. Some other common conditions that can be confused with and need to be differentiated from syncope include seizure disorders, sleep disturbances, accidental falls, and some psychotic conditions like conversion disorder. Cardiac syncope (from vascular disease, cardiomyopathy, arrhythmias, or valvular dysfunction) is associated with increased mortality, whereas noncardiac syncope is not. Syncope may result in significant morbidity and disability due to falls or accidents that occur as a result [10]. Besides the social impact of syncope with worsening quality of life, there is also the economic impact, with higher costs attributed to hospitalization with an estimated $2.4 billion annual cost [11].
All of the causes of syncope need to be evaluated. The evaluation usually begins with a detailed history and physical exam. Many of the causes of syncope like orthostatic hypotension can be diagnosed reasonably well based on the history and physical exam. However, many cases require further evaluation and workup. Most patients do undergo some form of cardiac assessment too. Most patients undergo an EKG to detect any arrhythmia, though it does not always show a paroxysmal arrhythmia, and such patient may need to have a further evaluation like a Holter monitor placed if the index of suspicion is high. On the other hand, an EKG does not help much with the diagnosis of syncope from structural heart disease or cardiopulmonary disease. Most patients who are suspected of having a cardiac origin of syncope also undergo transthoracic echocardiography (TTE) [12].
TTE can be useful in the evaluation of patients who present with syncope. It is especially helpful in identify any underlying cause and also stratify the severity of any underlying cardiac lesions, like severe aortic stenosis, hypertrophic cardiomyopathy, and left ventricular dysfunction [13-15]. It has been reported as the most useful imaging study for evaluating the severity of underlying cardiac disease and for the risk stratification of patients who had unexplained syncopal events especially those with a prior known positive cardiac history or an abnormal electrocardiogram (EKG) [16]. However, the exact role of echocardiography in the evaluation of syncope is still not clear, especially in patients with no cardiac history and no positive findings in the history, physical examination, and initial evaluation [17,18]. In patients with a cardiac history or an abnormal EKG, it is usually recommended to be part of the evaluation of syncope [19,20]. Since there is significant utilization of financial and human resources for echocardiography, there have been studies performed previously, and attempts have been made to streamline the approach to performing TTE in patients presenting with syncope [21,22].
2D-TTE is widely used as a screening tool to rule out structural or valvular heart disease in patients presenting with syncope. The significance cannot be undermined in high-risk patients who have underlying cardiomyopathy and present with unexplained syncope along with an abnormal physical exam and/or abnormal EKG. Echocardiography in patients with a normal physical exam and normal EKG is not very helpful and only adds to the additional cost to the patient and increase the length of stay. The average cost of echocardiogram in the US is between $1000-$3000 [23]. In clinical practice, inappropriately performed TTE can increase the healthcare cost and delays the timely interpretation of relevant studies.
There have been questions regarding the role of transthoracic echo in evaluating patients with syncope, primarily as to who warrants it. ACC/AHA/HRS guidelines recommend patients who have a positive history of cardiac disease, positive findings in the history and physical exam and an abnormal EKG should undergo a transthoracic echo. It is especially helpful in diagnosing the presence of valvular conditions like Aortic stenosis, Hypertrophic cardiomyopathy and severe left ventricular dysfunction that can at times present with syncope [23,24].
There have been previous studies to elucidate the role of transthoracic echo in syncope. In one retrospective review by Recchia et al., 48% of patients who had suspected cardiac disease based on history, physical exam, or EKG had an abnormal echocardiography [21].
In another prospective analysis of 650 patients by Sarasin et al., 24 of the 88 patients found to have an abnormal EKG were found to have systolic dysfunction on echocardiography. Half of these patients were found to have manifest arrhythmias too [12]. Our study is consistent with these prior studies, showing that an echo is more useful and has a higher yield in high-risk patients.
Limitations
Our study is a small retrospective study and is not as significant as a large prospective study would be. Secondly, we do not have to follow up with these patients after hospital discharge. Thirdly, reporting physical examination can be variable among physicians.
Conclusion
Echocardiography is frequently used in patients who are admitted with a diagnosis of syncope. Our study suggests that the use of echocardiography in patients with normal physical examination and normal electrocardiogram is very minimal. The utility of echocardiography in an appropriate subset of patients is high and this data provide an objective basis to prospectively define the optimal role of echocardiography in the evaluation of patients with syncope.
Acknowledgements
We thank Dr. Boigon for providing research opportunities in hospital.
Informed consent was waived via IRB.
Disclosure of conflict of interest
None.
References
- 1.Walsh K, Hoffmayer K, Hamdan MH. Syncope: diagnosis and management. Curr Probl Cardiol. 2015;40:51–86. doi: 10.1016/j.cpcardiol.2014.11.001. [DOI] [PubMed] [Google Scholar]
- 2.Kapoor WN. Syncope. N Engl J Med. 2000;343:1856–1862. doi: 10.1056/NEJM200012213432507. [DOI] [PubMed] [Google Scholar]
- 3.Colman N, Nahm K, Ganzeboom KS, Shen WK, Reitsma J, Linzer M, Wieling W, Kaufmann H. Epidemiology of reflex syncope. Clin Auton Res. 2004;14(Suppl 1):9–17. doi: 10.1007/s10286-004-1003-3. [DOI] [PubMed] [Google Scholar]
- 4.da Silva RM. Syncope: epidemiology, etiology, and prognosis. Front Physiol. 2014;5:471. doi: 10.3389/fphys.2014.00471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Task Force for the Diagnosis and Management of Syncope; European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA); Heart Failure Association (HFA); Heart Rhythm Society (HRS) Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, Deharo JC, Gajek J, Gjesdal K, Krahn A, Massin M, Pepi M, Pezawas T, Ruiz Granell R, Sarasin F, Ungar A, van Dijk JG, Walma EP, Wieling W. Guidelines for the diagnosis and management of syncope (version 2009) Eur Heart J. 2009;30:2631–2671. doi: 10.1093/eurheartj/ehp298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lewis DA, Dhala A. Syncope in the pediatric patient. The cardiologist’s perspective. Pediatr Clin North Am. 1999;46:205–219. doi: 10.1016/s0031-3955(05)70113-9. [DOI] [PubMed] [Google Scholar]
- 7.Serletis A, Rose S, Sheldon AG, Sheldon RS. Vasovagal syncope in medical students and their first-degree relatives. Eur Heart J. 2006;27:1965–1970. doi: 10.1093/eurheartj/ehl147. [DOI] [PubMed] [Google Scholar]
- 8.Lipsitz LA, Wei JY, Rowe JW. Syncope in an elderly, institutionalised population: prevalence, incidence, and associated risk. Q J Med. 1985;55:45–54. [PubMed] [Google Scholar]
- 9.Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ, Levy D. Incidence and prognosis of syncope. N Engl J Med. 2002;347:878–885. doi: 10.1056/NEJMoa012407. [DOI] [PubMed] [Google Scholar]
- 10.Ungar A, Mussi C, Nicosia F, Ceccofiglio A, Bellelli G, Bo M, Riccio D, Landi F, Martone AM, Langellotto A, Ghidoni G, Noro G, Abete P. The “syncope and dementia” study: a prospective, observational, multicenter study of elderly patients with dementia and episodes of “suspected” transient loss of consciousness. Aging Clin Exp Res. 2015;27:877–882. doi: 10.1007/s40520-015-0354-z. [DOI] [PubMed] [Google Scholar]
- 11.Sun BC. Quality-of-life, health service use, and costs associated with syncope. Prog Cardiovasc Dis. 2013;55:370–375. doi: 10.1016/j.pcad.2012.10.009. [DOI] [PubMed] [Google Scholar]
- 12.Sarasin FP, Louis-Simonet M, Carballo D, Slama S, Rajeswaran A, Metzger JT, Lovis C, Unger PF, Junod AF. Prospective evaluation of patients with syncope: a population-based study. Am J Med. 2001;111:177–184. doi: 10.1016/s0002-9343(01)00797-5. [DOI] [PubMed] [Google Scholar]
- 13.Middlekauff HR, Stevenson WG, Stevenson LW, Saxon LA. Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol. 1993;21:110–116. doi: 10.1016/0735-1097(93)90724-f. [DOI] [PubMed] [Google Scholar]
- 14.Crane SD. Risk stratification of patients with syncope in an accident and emergency department. Emerg Med J. 2002;19:23–7. doi: 10.1136/emj.19.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Bachinsky WB, Linzer M, Weld L, Estes NA 3rd. Usefulness of clinical characteristics in predicting the outcome of electrophysiologic studies in unexplained syncope. Am J Cardiol. 1992;69:1044–9. doi: 10.1016/0002-9149(92)90861-r. [DOI] [PubMed] [Google Scholar]
- 16.Sarasin FP, Junod AF, Carballo D, Slama S, Unger PF, Louis-Simonet M. Role of echocardiography in the evaluation of syncope: a prospective study. Heart. 2002;88:363–367. doi: 10.1136/heart.88.4.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Linzer M, Yang EH, Estes NA 3rd, Wang P, Vorperian VR, Kapoor WN. Diagnosing syncope. Part 1: value of history, physical examination, and electrocardiography. Clinical efficacy assessment project of the American college of physicians. Ann Intern Med. 1997;126:989–996. doi: 10.7326/0003-4819-126-12-199706150-00012. [DOI] [PubMed] [Google Scholar]
- 18.Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davidson TW, Davis JL, Douglas PS, Gillam LD. ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. Circulation. 1997;95:1686–1744. doi: 10.1161/01.cir.95.6.1686. [DOI] [PubMed] [Google Scholar]
- 19.Brignole M, Alboni P, Benditt DG, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, van Dijk JG, Fitzpatrick A, Hohnloser S, Janousek J, Kapoor W, Kenny RA, Kulakowski P, Masotti G, Moya A, Raviele A, Sutton R, Theodorakis G, Ungar A, Wieling W Task Force on Syncope, European Society of Cardiology. Guidelines on management (diagnosis and treatment) of syncope--update 2004. Europace. 2004;6:467–537. doi: 10.1016/j.eupc.2004.08.008. [DOI] [PubMed] [Google Scholar]
- 20.Shen WK, Sheldon RS, Benditt DG, Cohen MI, Forman DE, Goldberger ZD, Grubb BP, Hamdan MH, Krahn AD, Link MS, Olshansky B, Raj SR, Sandhu RK, Sorajja D, Sun BC, Yancy CW. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017;136:e60–e122. doi: 10.1161/CIR.0000000000000499. [DOI] [PubMed] [Google Scholar]
- 21.Recchia D, Barzilai B. Echocardiography in the evaluation of patients with syncope. J Gen Intern Med. 1995;10:649–655. doi: 10.1007/BF02602755. [DOI] [PubMed] [Google Scholar]
- 22.Panther R, Mahmood S, Gal R. Echocardiography in the diagnostic evaluation of syncope. J Am Soc Echocardiogr. 1998;11:294–298. doi: 10.1016/s0894-7317(98)70092-6. [DOI] [PubMed] [Google Scholar]
- 23.American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Echocardiography; American Heart Association; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Critical Care Medicine; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; American College of Chest Physicians. Douglas PS, Garcia MJ, Haines DE, Lai WW, Manning WJ, Patel AR, Picard MH, Polk DM, Ragosta M, Parker Ward R, Weiner RB. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 appropriate use criteria for echocardiography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance American College of Chest Physicians. J Am Soc Echocardiogr. 2011;24:229–267. doi: 10.1016/j.echo.2010.12.008. [DOI] [PubMed] [Google Scholar]
- 24.Chiu DT, Shapiro NI, Sun BC, Mottley JL, Grossman SA. Are echocardiography, telemetry, ambulatory electrocardiography monitoring, and cardiac enzymes in emergency department patients presenting with syncope useful tests? A preliminary investigation. J Emerg Med. 2014;47:113–118. doi: 10.1016/j.jemermed.2014.01.018. [DOI] [PubMed] [Google Scholar]